PL3621614T3 - Lotion zawierający tazaroten do stosowania miejscowego w leczeniu trądziku - Google Patents

Lotion zawierający tazaroten do stosowania miejscowego w leczeniu trądziku

Info

Publication number
PL3621614T3
PL3621614T3 PL18727965.8T PL18727965T PL3621614T3 PL 3621614 T3 PL3621614 T3 PL 3621614T3 PL 18727965 T PL18727965 T PL 18727965T PL 3621614 T3 PL3621614 T3 PL 3621614T3
Authority
PL
Poland
Prior art keywords
tazarotene
acne
lotion
treatment
topical use
Prior art date
Application number
PL18727965.8T
Other languages
English (en)
Polish (pl)
Inventor
Arturo Angel
Radhakrishnan Pillai
Original Assignee
Bausch Health Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch Health Ireland Limited filed Critical Bausch Health Ireland Limited
Publication of PL3621614T3 publication Critical patent/PL3621614T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
PL18727965.8T 2017-05-12 2018-05-11 Lotion zawierający tazaroten do stosowania miejscowego w leczeniu trądziku PL3621614T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762505421P 2017-05-12 2017-05-12
PCT/US2018/032359 WO2018209262A1 (en) 2017-05-12 2018-05-11 Topical compositions and methods for treating skin diseases

Publications (1)

Publication Number Publication Date
PL3621614T3 true PL3621614T3 (pl) 2025-10-13

Family

ID=62386996

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18727965.8T PL3621614T3 (pl) 2017-05-12 2018-05-11 Lotion zawierający tazaroten do stosowania miejscowego w leczeniu trądziku

Country Status (8)

Country Link
US (1) US20180360752A1 (enExample)
EP (1) EP3621614B1 (enExample)
JP (1) JP7410720B2 (enExample)
BR (1) BR112019023817A8 (enExample)
CA (1) CA3063371A1 (enExample)
PL (1) PL3621614T3 (enExample)
RS (1) RS67211B1 (enExample)
WO (1) WO2018209262A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108282998B (zh) 2015-06-18 2021-07-06 凡利亚药品北美公司 用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
CA3267519A1 (en) * 2022-09-16 2024-03-21 Bausch Health Ireland Ltd METHODS FOR TREATING ACNE AND OILY SKIN WITH TAZAROTENE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1210041C (zh) * 2003-09-29 2005-07-13 中国医学科学院皮肤病研究所 治疗痤疮的复方外用药物
CN108282998B (zh) * 2015-06-18 2021-07-06 凡利亚药品北美公司 用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物

Also Published As

Publication number Publication date
JP7410720B2 (ja) 2024-01-10
BR112019023817A8 (pt) 2022-12-06
JP2020519656A (ja) 2020-07-02
BR112019023817A2 (pt) 2020-06-02
CA3063371A1 (en) 2018-11-15
RS67211B1 (sr) 2025-10-31
EP3621614A1 (en) 2020-03-18
US20180360752A1 (en) 2018-12-20
WO2018209262A1 (en) 2018-11-15
EP3621614B1 (en) 2025-06-25

Similar Documents

Publication Publication Date Title
IL253066A0 (en) Cannabis-based extracts and formulations for topical administration for use in the treatment of skin diseases
EP3151797A4 (en) Methods and devices for treating the skin
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
GB201818894D0 (en) Topically treated patterened tissue product
EP3003046A4 (en) Topical copper ion treatments in the dermatological areas of the body
IL266198A (en) Liposomal formulation for use in cancer treatment
EP3310366A4 (en) Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
EP3556368A4 (en) THERAPEUTIC FOR ONYCHOMYCOSIS
EP3131524A4 (en) Methods and compositions for topical delivery for skin care
ZA201906473B (en) Topical phenytoin for use in the treatment of peripheral neuropathic pain
EP3228302A4 (en) Hair deformation treatment agent
EP3228303A4 (en) Hair deformation treatment agent
EP3236992A4 (en) Peptides and their use in the treatment of skin
HUE056401T2 (hu) Topikális készítmények és kezelések
GB2544813B (en) Devices and methods for delivering pharmaceuticals and cosmetics to the skin
PL3621614T3 (pl) Lotion zawierający tazaroten do stosowania miejscowego w leczeniu trądziku
IL225613A0 (en) Cosmetic formulation for local skin care
EP3380468B8 (en) Bis-pyridazine compounds and their use in treating cancer
GB201423268D0 (en) The combination for acne cleansing and skin metabolism improving
IL269121A (en) Usl-311 for use in the treatment of cancer
FR3034667B1 (fr) Composition cosmetique et/ou dermatologique contre l'acne
GB2557383B (en) Hair treatments
PT3340975T (pt) Formulação para o tratamento de acne
EP3150195A4 (en) Agent for external use on skin and agent for reducing skin irritation
IL269327A (en) A topical preparation for the treatment of dark skin